Vandetanib in Advanced Medullary Thyroid Cancer: Review of Adverse Event Management Strategies.
CONCLUSIONS: Good patient and team communication is necessary for the prevention, early detection, and management of AEs of vandetanib. Physicians, nurses, and other healthcare providers play a critical role in providing AE management and patient support to optimize outcomes with vandetanib in MTC.
PMID: 24249433 [PubMed - as supplied by publisher]
Source: Advances in Therapy - Category: Drugs & Pharmacology Authors: Grande E, Kreissl MC, Filetti S, Newbold K, Reinisch W, Robert C, Schlumberger M, Tolstrup LK, Zamorano JL, Capdevila J Tags: Adv Ther Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Dermatology | Drugs & Pharmacology | Education | Gastroenterology | Heart | Nurses | Nursing | Skin | Thyroid | Thyroid Cancer | Toxicology | Universities & Medical Training